A61K31/65 - page 4 - CPC Classification Index

#901

20150094273

2015-04-02

Pharmaceutical composition comprising sophorolipid in combination with an antibiotic

#902

20150087711

2015-03-26

Minocycline compounds and methods of use thereof

#903

20150087612

2015-03-26

Phthalocyanine compounds useful as RecA inhibitors and methods of using same

#904

20150071981

2015-03-12

SUSTAINED-RELEASE DRUG CARRIER COMPOSITION

#905

20150065416

2015-03-05

NOVEL DRUG COMBINATION

#906

20150064268

2015-03-05

NANOPARTICLES FOR STIMULATING ELASTOGENESIS

#907

20150057254

2015-02-26

ONCE DAILY FORMULATIONS OF TETRACYCLINES

#908

20150056149

2015-02-26

Topical tetracycline compositions

#909

20150050620

2015-02-19

PREVENTING OR TREATING PERIODONTAL DISEASE

#910

20150050340

2015-02-19

Sustained-release drug carrier composition

#911

20150045329

2015-02-12

Substituted tetracycline compounds

#912

20150044297

2015-02-12

Galenical system for active transport, method for preparation and use

#913

20150044173

2015-02-12

Microbiota restoration therapy (MRT), compositions and methods of manufacture

#914

20150038851

2015-02-05

Meibomian gland dysfunction

#915

20150038406

2015-02-05

Pharmaceutical formulations of tranexamic acid and their use

#916

20150025025

2015-01-22

Immuno-modulators for treating functional epithelial syndromes

#917

20150023975

2015-01-22

PAR-1 activation by metalloproteinase-1 (MMP-1)

#918

20150023905

2015-01-22

Synthetic mechanical hemostatic composition, method of making and use thereof

#919

20150018294

2015-01-15

MODULATORS OF TOUSLED KINASE IN CELLULAR PROCESSES

#920

20150004212

2015-01-01

Linear polyesteramides from aminophenolic esters

#921

20140377347

2014-12-25

IN-SITU MULTILAYERED TABLET TECHNOLOGY

#922

20140377268

2014-12-25

Cleavage inhibitors of transforming growth factor beta type I receptor and uses thereof in cancer therapy

#923

20140377176

2014-12-25

Functionalised silicon nanoparticles

#924

20140363479

2014-12-11

Compositions and methods for treating extracellular parasitic infections

#925

20140348823

2014-11-27

Histone deacetylase (HDAC) inhibitors for the treatment of cancer

#926

20140343003

2014-11-20

Method for treating Lyme disease

#927

20140335132

2014-11-13

BINDING DRUGS WITH NANOCRYSTALLINE CELLULOSE (NCC)

#928

20140335047

2014-11-13

Drug delivery product and methods

#929

20140328770

2014-11-06

Topical tetracycline compositions

#930

20140323443

2014-10-30

TIGECYCLINE FORMULATIONS

#931

20140314665

2014-10-23

Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof

#932

20140309198

2014-10-16

METHOD OF TREATING ACNE

#933

20140274972

2014-09-18

Methods employing wolbachia FtsZ as a target for albendazole sulfone

#934

20140274971

2014-09-18

Systems and methods of using chemically bound antibiotics activated by infections

#935

20140274970

2014-09-18

Controlled release pharmaceutical dosage forms

#936

20140274969

2014-09-18

USE OF MINOCYCLINE FOR THERAPEUTIC TREATMENT OF ACUTE SPINAL CORD INJURIES

#937

20140274905

2014-09-18

METHODS AND COMPOUNDS FOR CALCIUM ION CHANNEL REGULATION

#938

20140271921

2014-09-18

Pharmaceutical composition

#939

20140271912

2014-09-18

Sodium containing sol-gel derived bioactive glasses and uses thereof including hemostasis

#940

20140271845

2014-09-18

COATED SUBSTRATE COMPOSITIONS

#941

20140271834

2014-09-18

Doxycycline Formulations, and Methods of Treating Rosacea

#942

20140271777

2014-09-18

Anti-biofilm compositions and methods for using

#943

20140256661

2014-09-11

PHARMACEUTICAL COMPOSITIONS FOR RECTAL ADMINISTRATION

#944

20140256616

2014-09-11

MODIFIED GREEN TEA POLYPHENOL FORMULATIONS

#945

20140255479

2014-09-11

Pharmaceuticals for oral delivery

#946

20140249085

2014-09-04

Calcitonin products and therapies for treating inflammatory or degenerative diseases

#947

20140242026

2014-08-28

Compounds, compositions, and methods for preventing metastasis of cancer cells

#948

20140227272

2014-08-14

Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains

#949

20140221922

2014-08-07

Absorbable crystalline polyether-ester-urethane-based bioactive luminal liner compositions

#950

20140221320

2014-08-07

TOPICAL MINOCYCLINE OINTMENT FOR SUPPRESSION OF ALLERGIC SKIN RESPONSES

#951

20140221301

2014-08-07

COMBINATION TREATMENT FOR CANCER

#952

20140206636

2014-07-24

METHODS OF DIAGNOSING AND TREATING SMALL INTESTINAL BACTERIAL OVERGROWTH (SIBO) AND SIBO-RELATED CONDITIONS

#953

20140205662

2014-07-24

SYSTEM AND METHOD FOR DIFFERENTIALLY TIMED LOCAL DELIVERY OF A COMBINATION PHARMACEUTICAL PREPARATION FOR ORAL THERAPY

#954

20140205643

2014-07-24

Use of alginate oligomers in combating biofilms

#955

20140199469

2014-07-17

SUSTAINED-RELEASE TABLET AND PROCESS FOR PREPARING THE SAME

#956

20140199376

2014-07-17

Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof

#957

20140199375

2014-07-17

Combination therapy for skin disorders

#958

20140199289

2014-07-17

Use of matrix metalloproteinase inhibitors to treat tuberculosis

#959

20140194393

2014-07-10

Tetracycline compositions

#960

20140187611

2014-07-03

Mitochondrial ribosomal proteins as aging regulators

#961

20140186442

2014-07-03

Topical minocycline compositions and methods of using the same

#962

20140179639

2014-06-26

MELOXICAM FOR THE TREATMENT OF RESPIRATORY DISEASES IN PIGS

#963

20140179638

2014-06-26

9-aminomethyl substituted tetracycline compounds

#964

20140179637

2014-06-26

METHODS AND COMPOUNDS TO INHIBIT ENVELOPED VIRUS RELEASE

#965

20140170162

2014-06-19

PRESERVATION OF THE NEUROMUSCULAR JUNCTION (NMJ) AFTER TRAUMATIC NERVE INJURY

#966

20140148402

2014-05-29

Diagnostic assays and methods of treating pneumonia, sepsis and systemic inflammatory response syndrome

#967

20140147504

2014-05-29

Tetracycline topical formulations, preparation and uses thereof

#968

20140135296

2014-05-15

Methods of treating autophagy-associated disorders and related pharmaceutical compositions, diagnostics, screening techniques and kits

#969

20140128351

2014-05-08

COMBINATION THERAPY FOR SKIN DISORDERS

#970

20140128336

2014-05-08

MEDICAL PRODUCTS FOR USE IN CONDITIONS RELATED TO MICROBIAL INFECTIONS IN THE UPPER AERODIGESTIVE TRACT

#971

20140128335

2014-05-08

Use of polyaminoisoprenyl derivatives in antibiotic or antiseptic treatment

#972

20140121188

2014-05-01

COMPOSITIONS FOR THE IMPROVED TREATMENT OF ACNE AND RELATED DISORDERS

#973

20140107357

2014-04-17

Tigecycline crystalline hydrate and preparation method therefor and use thereof

#974

20140100201

2014-04-10

CONNECTIVE TISSUE MONITORING, COMPOSITIONS FOR CONNECTIVE TISSUE TREATMENT AND METHODS FOR TREATING CONNECTIVE TISSUE

#975

20140100200

2014-04-10

METHODS OF TREATING ACNE

#976

20140087000

2014-03-27

Method and System for Treatment of Biological Tissue

#977

20140086975

2014-03-27

HYDROGEL FORMULATION FOR DERMAL AND OCULAR DELIVERY

#978

20140073611

2014-03-13

METHODS FOR DRUG SCREEN USING ZEBRAFISH MODEL AND THE COMPOUNDS SCREENED THEREFROM

#979

20140072626

2014-03-13

Once daily formulations of tetracyclines

#980

20140066524

2014-03-06

Compositions, gels and foams with rheology modulators and uses thereof

#981

20140066365

2014-03-06

USE OF CALIXARENES ASSOCIATED WITH AN ANTIBIOTIC IN THE TREATMENT OF BACTERIAL INFECTIONS

#982

20140050673

2014-02-20

Oil-based foamable carriers and formulations

#983

20140038883

2014-02-06

NOVEL AZACOUMARIN DERIVATIVES HAVING MDR PUMP INHIBITING ACTIVITY

#984

20140030317

2014-01-30

Modulation of cell fates and activities by phthalazinediones

#985

20140018324

2014-01-16

Method for improving tetracycline-resistance of

#986

20140018323

2014-01-16

Sustained-release injectable formulation

#987

20140010778

2014-01-09

Controlling Pseudomonas aeruginosa persister cells with GM-CSF

#988

20130345179

2013-12-26

Substituted tetracycline compounds for treatment of inflammatory skin disorders

#989

20130345146

2013-12-26

NEAR-INFRARED ELECTROMAGNETIC MODIFICATION OF CELLULAR STEADY-STATE MEMBRANE POTENTIALS

#990

20130344079

2013-12-26

Compositions and methods for diagnosing and treating phenylketonuria (PKU)

#991

20130338118

2013-12-19

Compounds for treatment of heart failure

#992

20130338117

2013-12-19

Therapeutic compounds for blocking DNA synthesis of POX viruses

#993

20130338116

2013-12-19

COMPOUNDS AND METHODS FOR THE TREATMENT OF PAIN AND OTHER DISEASES

#994

20130324500

2013-12-05

SPINAL CORD INJURY, INFLAMMATION AND IMMUNE-DISEASE: LOCAL CONTROLLED RELEASE OF THERAPEUTIC AGENTS

#995

20130310346

2013-11-21

Methods and compositions for treating bacterial infections with iron chelators

#996

20130310345

2013-11-21

Use of TRPA1 antagonists to prevent or treat infections caused by biological-warfare agents

#997

20130302442

2013-11-14

METHODS OF USING (4S,4AS,5AR,12AS)-4-DIMETHYLAMINO-3,10,12,12A-TETRAHYDROXY-7-[(METHOXY(METHYL)AMINO)-METHYL]-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-NAPHTHACENE-2-CARBOXYLIC ACID AMIDE

#998

20130296228

2013-11-07

EFFLUX PUMP INHIBITORS

#999

20130295181

2013-11-07

Compositions based on propolis nanocapsules which can be used as carriers for substances of interest, methods for producing same and use thereof

#1000

20130272997

2013-10-17

Synthetic mechanical hemostatic composition, method of making and use thereof

#1001

20130231309

2013-09-05

TREATMENT OF INFLAMMATION AND ORGAN DYSFUNCTION

#1002

20130225536

2013-08-29

Methods for accelerated return of skin integrity and for the treatment of impetigo

#1003

20130224255

2013-08-29

Treatment of diabetic patients with a drug eluting stent and adjunctive therapy

#1004

20130217741

2013-08-22

Topical pharmaceutical compositions for treatment of skin damage

#1005

20130196954

2013-08-01

METHOD OF TREATING ACNE

#1006

20130196939

2013-08-01

Detection of DNA sequences as risk factors for HIV infection

#1007

20130195986

2013-08-01

Particles of tetracyclines and protecting agent

#1008

20130195751

2013-08-01

Self-assembed conjugate and use thereof

#1009

20130190275

2013-07-25

COMBINED THERAPIES OF ANTIPSYCHOTIC DRUGS AND TETRACYCLINES IN THE TREATMENT OF PSYCHIATRIC DISORDERS

#1010

20130190274

2013-07-25

TOPICAL DRUG DELIVERY SYSTEM WITH DUAL CARRIERS

#1011

20130189191

2013-07-25

Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof

#1012

20130172298

2013-07-04

and cancer

#1013

20130171210

2013-07-04

BISMUTH-THIOLS AS ANTISEPTICS FOR EPITHELIAL TISSUES, ACUTE AND CHRONIC WOUNDS, BACTERIAL BIOFILMS AND OTHER INDICATIONS

#1014

20130171105

2013-07-04

CANCER THERAPY USING A COMBINATION OF A HSP90 INHIBITORY COMPOUND AND A TOPOISOMERASE II INHIBITOR

#1015

20130165368

2013-06-27

ANTIMICROBIAL COMPOUNDS

#1016

20130157930

2013-06-20

Linear polyesteramides from aminophenolic esters

#1017

20130156816

2013-06-20

METHODS AND COMPOSITIONS FOR USE IN AQUACULTURE

#1018

20130144264

2013-06-06

Absorbable crystalline copolyester-based bioactive hydroforming luminal liner compositions

#1019

20130123217

2013-05-16

Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits

#1020

20130109657

2013-05-02

C7-fluoro substituted tetracycline compounds

#1021

20130109617

2013-05-02

Substituted tetracycline compounds for treatment of infections

#1022

20130102572

2013-04-25

METHODS OF TREATING SKIN CONDITIONS EXHIBITING TELANGIECTASIA

#1023

20130095188

2013-04-18

Method of Encapsulating a Material Using Solvent Removal Technique, and Microspheres/Nanospheres/Matrix Made Therefrom Having Sustained Release Properties

#1024

20130095087

2013-04-18

Absorbable in situ gel-forming system, method of making and use thereof

#1025

20130064777

2013-03-14

Surfactant-free water-free foamable compositions, breakable foams and gels and their uses

#1026

20130059824

2013-03-07

METHODS FOR TREATING MILD COGNITIVE IMPAIRMENT

#1027

20130059774

2013-03-07

EFFLUX PUMP INHIBITORS

#1028

20130058983

2013-03-07

Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses

#1029

20130058904

2013-03-07

Composition for modulating inflammation of cardiovascular tissue

#1030

20130053353

2013-02-28

COMPOSITIONS, GELS AND FOAMS WITH RHEOLOGY MODULATORS AND USES

#1031

20130045957

2013-02-21

Prevention of and Recovery from Drug-Induced Ototoxicity

#1032

20130040918

2013-02-14

Tetracycline compositions

#1033

20130028850

2013-01-31

Topical tetracycline compositions

#1034

20130011342

2013-01-10

Surfactant-free, water-free formable composition and breakable foams and their uses

#1035

20120329761

2012-12-27

USE OF TIGECYCLINE FOR TREATMENT OF CANCER

#1036

20120329760

2012-12-27

RNASE 7 AS A MARKER FOR INFECTION

#1037

20120322770

2012-12-20

Therapeutic compounds for blocking DNA synthesis of pox viruses

#1038

20120321571

2012-12-20

PARABEN COMPOSITIONS

#1039

20120315298

2012-12-13

Local treatment of neurofibromas

#1040

20120308608

2012-12-06

INTERFERON-INDUCING COMPOUNDS AND USES THEREOF

#1041

20120302527

2012-11-29

C7-fluoro substituted tetracycline compounds

#1042

20120302526

2012-11-29

METHODS FOR TREATING POST-TRAUMATIC STRESS DISORDER

#1043

20120283267

2012-11-08

Compositions and methods for the treatment of giardiasis

#1044

20120283225

2012-11-08

Combination therapy for skin disorders

#1045

20120283201

2012-11-08

9-substituted minocycline compounds

#1046

20120276121

2012-11-01

Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases

#1047

20120264678

2012-10-18

METHODS OF USING [3.2.0] HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF FOR TREATING INFECTIOUS DISEASES

#1048

20120263790

2012-10-18

Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions

#1049

20120258937

2012-10-11

Targeting Estrogen Receptors in the Treatment of Lymphangioleiomyomatosis

#1050

20120245130

2012-09-27

Methods of Using Substituted Tetracycline Compounds to Modulate RNA

#1051

20120245107

2012-09-27

METHODS OF REDUCING THE PROLIFERATION AND VIABLILITY OF MICROBIAL AGENTS

#1052

20120244216

2012-09-27

COATED PHARMACEUTICAL CAPSULE DOSAGE FORM

#1053

20120244157

2012-09-27

USE OF TNF-ALPHA INHIBITORS FOR TREATING A NERVE DISORDER MEDIATED BY NUCLEUS PULPOSUS

#1054

20120232040

2012-09-13

MEDICATION FOR CLINICAL EXTENSIVELY-DRUG RESISTANT ACINETOBACTER BAUMANNII

#1055

20120225064

2012-09-06

Sphingosine 1-Phosphate Antagonism

#1056

20120220555

2012-08-30

Methods of Simultaneously Treating Ocular Rosacea and Acne Rosacea

#1057

20120219523

2012-08-30

Method of treating tuberculosis with interferons

#1058

20120207826

2012-08-16

Compositions and methods for treating extracellular parasitic infections

#1059

20120195984

2012-08-02

DIAGNOSIS AND TREATMENT OF THE PRODROMAL SCHIZOPHRENIC STATE

#1060

20120190653

2012-07-26

THERAPEUTIC EYE DROP COMPRISING DOXYCYCLINE AND A STABILIZER

#1061

20120190632

2012-07-26

Anti-bacterial infection, inflammation, and leukemia composition and use thereof

#1062

20120189710

2012-07-26

ANTIBACTERIAL COMPOSITIONS

#1063

20120183629

2012-07-19

LOW VISCOSITY LIQUID POLYMERIC DELIVERY SYSTEM

#1064

20120183621

2012-07-19

Synergistic combinations to reduce particle dose for targeted treatment of cancer and its metastases

#1065

20120181201

2012-07-19

Topical Formulation Containing a Tetracycline and a Method of Treating Skin Infections Using the Same

#1066

20120177620

2012-07-12

Probiotic, lactic acid-producing bacteria

#1067

20120165795

2012-06-28

Therapeutic agent reservoir delivery system

#1068

20120148514

2012-06-14

N-ALKYL LACTAM ETHERS, AND COMPOSITIONS AND USES THEREOF

#1069

20120142589

2012-06-07

TISSUE-PROTECTIVE CYTOKINES FOR THE PROTECTION, RESTORATION AND ENHANCEMENT OF RESPONSIVE CELLS, TISSUES AND ORGANS

#1070

20120141590

2012-06-07

Technology for the Preparation of Microparticles

#1071

20120128625

2012-05-24

Compounds, compositions, and methods for preventing metastasis of cancer cells

#1072

20120122768

2012-05-17

Alginate oligomers for use in overcoming multidrug resistance in bacteria

#1073

20120121706

2012-05-17

PAR-1 Activation by Metalloproteinase-1 (MMP-1)

#1074

20120121693

2012-05-17

Methods for generating new hair follicles, treating baldness, and hair removal

#1075

20120115803

2012-05-10

Treatment of Acinetobacter with alginate oligomers and antibiotics

#1076

20120114756

2012-05-10

Sustained-release drug carrier composition

#1077

20120114670

2012-05-10

METHODS AND COMPOSITIONS RELATED TO SYNERGISTIC RESPONSES TO ONCOGENIC MUTATIONS

#1078

20120114605

2012-05-10

Methods and compositions relating to hematologic malignancies

#1079

20120108552

2012-05-03

Methods of treating acne

#1080

20120101071

2012-04-26

SubstitutedTetracycline Compounds for the Treatment of Malaria

#1081

20120100214

2012-04-26

Sustained-Release Tablet and Process for Preparing the Same

#1082

20120093892

2012-04-19

MINOCYCLINE ORAL DOSAGE FORMS FOR THE TREATMENT OF ACNE

#1083

20120093876

2012-04-19

Ophthalmic Formulations, Methods Of Manufacture And Methods of Normalizing Meibomian Gland Secretions

#1084

20120093816

2012-04-19

Use of TNF-alpha Inhibitors for Treating a Nerve Disorder Mediated by Nucleus Pulposus

#1085

20120093759

2012-04-19

Medical Devices, Wound Dressings, and Methods for Dressing Wounds

#1086

20120088739

2012-04-12

METHOD FOR TREATING MEIBOMIAN GLAND DISEASE

#1087

20120088671

2012-04-12

Anti-biofilm compositions and methods for using

#1088

20120082659

2012-04-05

Methods And Compositions Related To Synergistic Responses To Oncogenic Mutations

#1089

20120082632

2012-04-05

Topical drug delivery system with dual carriers

#1090

20120076872

2012-03-29

MODIFIED GREEN TEA POLYPHENOL FORMULATIONS

#1091

20120076766

2012-03-29

Topical drug delivery system with dual carriers

#1092

20120076742

2012-03-29

Topical drug delivery system with dual carriers

#1093

20120071410

2012-03-22

CALCITONIN PRODUCTS AND THERAPIES FOR TREATING INFLAMMATORY OR DEGENERATIVE DISEASES

#1094

20120070390

2012-03-22

Topical drug delivery system with dual carriers

#1095

20120064145

2012-03-15

WOUND DRESSING

#1096

20120052292

2012-03-01

Medical device coatings

#1097

20120046556

2012-02-23

Methods and Kits for Preventing the Spread of Sexually Transmitted Microorganisms

#1098

20120046249

2012-02-23

METHODS OF REDUCING THE RISK OF CARDIOVASCULAR DISEASE IN POSTMENOPAUSAL WOMEN

#1099

20120040925

2012-02-16

ARYL UREA COMPOUNDS IN COMBINATION WITH OTHER CYTOSTATIC OR CYTOTOXIC AGENTS FOR TREATING HUMAN CANCERS

#1100

20120028929

2012-02-02

TETRACYCLINE STABILIZING FORMULATIONS

#1101

20120028928

2012-02-02

Process for isolating tigecycline and tigecycline made therefrom

#1102

20120027855

2012-02-02

PHARMACEUTICAL COMPOSITIONS FOR GASTROINTESTINAL DRUG DELIVERY

#1103

20120022001

2012-01-26

Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle

#1104

20120016347

2012-01-19

Seroma Control for Surgical Patients

#1105

20120003155

2012-01-05

Dendrimer based nanodevices for therapeutic and imaging purposes

#1106

20110319368

2011-12-29

Once daily formulations of tetracyclines

#1107

20110307967

2011-12-15

TetO-p16 transgenic mice

#1108

20110301129

2011-12-08

Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract

#1109

20110294760

2011-12-01

Compositions and methods for preventing sternal wound infections

#1110

20110294759

2011-12-01

Once daily formulations of tetracyclines

#1111

20110288056

2011-11-24

Once daily formulations of tetracyclines

#1112

20110281827

2011-11-17

Compositions, gels and foams with rheology modulators and uses thereof

#1113

20110275558

2011-11-10

Lanthionine synthetase component C-like proteins as molecular targets for preventing and treating diseases and disorders

#1114

20110269720

2011-11-03

MINOCYCLINE AND RIFAMPIN MICROPARTICLES

#1115

20110268665

2011-11-03

Oil-based foamable carriers and formulations

#1116

20110262556

2011-10-27

SILVER/WATER, SILVER GELS AND SILVER-BASED COMPOSITIONS; AND METHODS FOR MAKING AND USING THE SAME

#1117

20110256203

2011-10-20

Method for manufacturing a porous ceramic scaffold having an organic/inorganic hybrid coating layer containing a bioactive factor

#1118

20110256073

2011-10-20

Formulations for treating and/or preventing black-line stains

#1119

20110245501

2011-10-06

Substituted Tetracycline Compounds as Synergistic Antifungal Agents

#1120

20110230452

2011-09-22

Compounds and methods for the treatment of pain and other diseases

#1121

20110223111

2011-09-15

Calcium carbonate microstructures useful in encapsulation applications and a process for the preparation thereof

#1122

20110218139

2011-09-08

Combination therapy and methods for treating bacterial biofilms

#1123

20110212156

2011-09-01

Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics

#1124

20110212138

2011-09-01

Sustained release formulations using non-aqueous carriers

#1125

20110212033

2011-09-01

Oil and liquid silicone foamable carriers and formulations

#1126

20110207706

2011-08-25

Methods for treating spinal muscular atrophy using tetracycline compounds

#1127

20110189256

2011-08-04

Reduction of infection associated with medical device

#1128

20110183943

2011-07-28

Concurrent therapy regime/regimen for the treatment of acne related diseases

#1129

20110171299

2011-07-14

Doxycycline metal complex in a solid dosage form

#1130

20110171232

2011-07-14

Methods of treating autoimmune diseases caused by small intestinal bacterial overgrowth

#1131

20110160156

2011-06-30

Pharmaceutical Composition for the Eradication of Helicobacter Pylori and Preparation Method Thereof

#1132

20110152746

2011-06-23

Methods for generating new hair follicles, treating baldness, and hair removal

#1133

20110144003

2011-06-16

Maintenance therapy regime/regimen for the treatment of acne

#1134

20110124681

2011-05-26

TOPICAL AND INJECTABLE FORMULATIONS COMPRISING LEUKOTRIENE RECEPTOR ANTAGONIST AND USES THEREOF

#1135

20110123517

2011-05-26

DISSOLVABLE PHARMACEUTICAL IMPLANT

#1136

20110118216

2011-05-19

Tigecycline compositions and methods of preparation

#1137

20110117197

2011-05-19

Sustained-release drug carrier composition

#1138

20110104308

2011-05-05

Treatment For Diseases Relying On Discovery That Thioredoxin Mediates Nitric Oxide

#1139

20110098266

2011-04-28

Method of administering an injectable antibiotic to an animal

#1140

20110098255

2011-04-28

COMBINATION OF A PARP INHIBITOR AND AN AKT KINASE ACTIVATING COMPOUND

#1141

20110097377

2011-04-28

Methods and devices for correcting spinal deformity with pharmaceutical-eluting pedicle screws

#1142

20110092421

2011-04-21

Methods for generating new hair follicles, treating baldness, and hair removal

#1143

20110086821

2011-04-14

Tetracycline Compounds for Treatment of Cryptosporidium Parvum Related Disorders

#1144

20110082305

2011-04-07

7-phenyl-substituted tetracycline compounds

#1145

20110065637

2011-03-17

Method to reduce SLOSH energy absorption and its damaging effects through the reduction of inelastic collisions in an organism

#1146

20110059925

2011-03-10

METHODS FOR IMPROVING LID MARGIN AND TEAR FILM FUNCTION AND TREATMENT OF LID MARGIN DISEASE USING TETRACYCLINE FAMILY ANTIBIOTICS

#1147

20110039806

2011-02-17

COMBINED THERAPIES OF ANTIPSYCHOTIC DRUGS AND TETRACYCLINES IN THE TREATMENT OF PSYCHIATRIC DISORDERS

#1148

20110039805

2011-02-17

METHOD FOR TREATING MEIBOMIAN GLAND DISEASE

#1149

20110039764

2011-02-17

THERAPEUTIC COMPOSITION FOR BONE INFECTIOUS DISEASE

#1150

20110034422

2011-02-10

Dendrimers for sustained release of compounds

#1151

20110033402

2011-02-10

Solubilized benzoyl small molecule

#1152

20110027389

2011-02-03

Low viscosity liquid polymeric delivery system

#1153

20110027368

2011-02-03

Polymeric compositions comprising therapeutic agents in crystalline phases, and methods of forming the same

#1154

20110021466

2011-01-27

Use of epicatechin and derivatives and salts thereof for cardiac protection of ischemic myocardium and to ameliorate adverse cardiac remodeling

#1155

20110020306

2011-01-27

Probiotic, lactic acid-producing bacteria and uses thereof

#1156

20110020305

2011-01-27

Probiotic, lactic acid-producing bacteria and uses thereof

#1157

20110003001

2011-01-06

Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications

#1158

20100330180

2010-12-30

TABLETTING PROCESS

#1159

20100330131

2010-12-30

Minocycline oral dosage forms for the treatment of acne

#1160

20100310476

2010-12-09

Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof

#1161

20100305178

2010-12-02

Pharmaceutical composition

#1162

20100305062

2010-12-02

Use of alginate oligomers in combating biofilms

#1163

20100303799

2010-12-02

Treatment of conditions related to shock

#1164

20100292193

2010-11-18

RADIOPROTECTIVE DRUGS

#1165

20100292183

2010-11-18

TETRACYCLINE AND USES THEREOF

#1166

20100291201

2010-11-18

COATED PHARMACEUTICAL CAPSULE DOSAGE FORM

#1167

20100291025

2010-11-18

INDAZOLE INHIBITORS OF TYROSINE KINASE

#1168

20100272736

2010-10-28

COMBINATION ANTIBIOTIC AND ANTIBODY THERAPY FOR THE TREATMENT OF PSEUDOMONAS AERUGINOSA INFECTION

#1169

20100266540

2010-10-21

AG-205 for the treatment of breast cancer

#1170

20100256081

2010-10-07

Absorbable crystalline copolyester-based bioactive hydroforming luminal liner compositions

#1171

20100255016

2010-10-07

Absorbable crystalline polyether-ester-urethane-based bioactive luminal liner compositions

#1172

20100247544

2010-09-30

Compositions and methods for promoting the healing of tissue of multicellular organisms

#1173

20100222271

2010-09-02

Formulation to improve gastrointestinal function

#1174

20100221357

2010-09-02

Drug delivery product and methods

#1175

20100221298

2010-09-02

Galenical system for active transport, method for preparation and use

#1176

20100216697

2010-08-26

Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition

#1177

20100215754

2010-08-26

Delivery system for functional compounds

#1178

20100215744

2010-08-26

Hydroxypropyl Substitution Used to Regulate Dissolution of a Chemical

#1179

20100215716

2010-08-26

COMPOSITIONS AND METHODS FOR COATING ORTHOPEDIC IMPLANTS

#1180

20100210616

2010-08-19

METAL COMPLEXES INCORPORATED WITHIN BIODEGRADABLE NANOPARTICLES AND THEIR USE

#1181

20100209538

2010-08-19

PH-MODULATED FORMULATIONS FOR PULMONARY DELIVERY

#1182

20100209507

2010-08-19

Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions

#1183

20100203100

2010-08-12

ANTIMICROBIAL ACCESSORY FOR AN IMPLANTABLE MEDICAL DEVICE

#1184

20100198278

2010-08-05

COMPOSITE ANTIMICROBIAL ACCESSORY INCLUDING A MEMBRANE LAYER AND A POROUS LAYER

#1185

20100197621

2010-08-05

METHODS OF REDUCING THE PROLIFERATION AND VIABILITY OF MICROBIAL AGENTS

#1186

20100196481

2010-08-05

SPINAL CORD INJURY, INFLAMMATION, AND IMMUNE-DISEASE: LOCAL CONTROLLED RELEASE OF THERAPEUTIC AGENTS

#1187

20100190756

2010-07-29

3, 10, and 12a substituted tetracycline compounds

#1188

20100190755

2010-07-29

TETRACYCLINE COMPOUNDS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AND RELATED METHODS OF TREATMENT

#1189

20100168046

2010-07-01

METHODS OF USING [3.2.0] HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF FOR TREATING INFECTIOUS DISEASES

#1190

20100160656

2010-06-24

7-phenyl-substituted tetracycline compounds

#1191

20100150922

2010-06-17

Use of an antibody that blocks TNF-alpha activity for treating a nerve disorder mediated by nucleus pulposus

#1192

20100137261

2010-06-03

Method for treating aortic stenosis with non-antibacterial tetracycline formulations

#1193

20100137198

2010-06-03

Pharmaceutical composition for topical application

#1194

20100130452

2010-05-27

Use of Doxycycline in the Treatment of Idiopathic Pulmonary Fibrosis

#1195

20100129366

2010-05-27

THIAZOLE INHIBITORS OF CYCLOOXYGENASE

#1196

20100119508

2010-05-13

Phenylacetic acid inhibitors of cyclooxygenase

#1197

20100113399

2010-05-06

Salts and polymorphs of 9-(2,2-dimethylpropyl-aminomethyl) minocycline

#1198

20100105671

2010-04-29

C7-fluoro substituted tetracycline compounds

#1199

20100098660

2010-04-22

Method of treating tuberculosis with interferons

#1200

20100092579

2010-04-15

Medicament for treating lung cancer